Etrinabdione (C007B-579988)

Etrinabdione (EHP-101; VCE-004.8) is a specific PPARγ and CB2 receptor dual agonist. Etrinabdione inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. Etrinabdione, a semi-synthetic multitarget cannabinoquinoid, has potent anti-inflammatory activity. Etrinabdione attenuates adipogenesis and prevents diet-induced obesity .

Specifictaions: Moligand™, ≥98%

MDL Number: C28H35NO3

Molecular Formula: 433.58

PubChem CID: 118465221

Isomeric SMILES: CCCCCC1=C(C(=C(C(=O)C1=O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O)NCC3=CC=CC=C3

UPC:

51111739

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

E650944-25mg

CAS:

1818428-24-8

Product Size:

25mg